18.95
Precedente Chiudi:
$18.93
Aprire:
$18.97
Volume 24 ore:
313.53K
Relative Volume:
0.68
Capitalizzazione di mercato:
$534.41M
Reddito:
$242.12M
Utile/perdita netta:
$-351.72M
Rapporto P/E:
-1.4259
EPS:
-13.29
Flusso di cassa netto:
$24.82M
1 W Prestazione:
+0.53%
1M Prestazione:
+1.17%
6M Prestazione:
+42.37%
1 anno Prestazione:
+11.21%
Zimvie Inc Stock (ZIMV) Company Profile
Nome
Zimvie Inc
Settore
Industria
Telefono
800-342-5454
Indirizzo
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
Confronta ZIMV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ZIMV
Zimvie Inc
|
18.95 | 534.41M | 242.12M | -351.72M | 24.82M | -13.29 |
![]()
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-31 | Downgrade | B. Riley Securities | Buy → Neutral |
2025-07-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
2025-04-10 | Iniziato | B. Riley Securities | Buy |
2025-03-13 | Downgrade | Needham | Buy → Hold |
2024-05-16 | Aggiornamento | Needham | Hold → Buy |
2023-11-16 | Iniziato | Needham | Hold |
2022-12-21 | Iniziato | Barclays | Underweight |
2022-06-17 | Iniziato | JP Morgan | Neutral |
2022-03-18 | Iniziato | Guggenheim | Neutral |
Mostra tutto
Zimvie Inc Borsa (ZIMV) Ultime notizie
ZIM's Q2 2025 Earnings and Strategic Outlook Amid ZimVie's Pending Acquisition: Clarifying the Market's Confusion - AInvest
ZimVie Inc. Approaches Support With Recovery in SightJuly 2025 Fed Impact & High Win Rate Trade Alerts - thegnnews.com
Synovus, ZimVie, Mesa, Royal Gold Under Investigation for Potential Securities Law Violations - AInvest
What MACD and RSI say about ZimVie Inc.Inflation Watch & Fast Exit and Entry Strategy Plans - Newser
ZimVie Inc. stock momentum explained2025 Institutional Moves & Risk Controlled Swing Trade Alerts - Newser
Forecasting ZimVie Inc. price range with options dataJuly 2025 Summary & Real-Time Stock Price Movement Reports - Newser
Using RSI to spot recovery in ZimVie Inc.Weekly Profit Summary & Consistent Return Investment Signals - Newser
Can swing trading help recover from ZimVie Inc. lossesTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
What makes ZimVie Inc. stock price move sharplyJuly 2025 Retail & Free Safe Entry Trade Signal Reports - Newser
What data driven models say about ZimVie Inc.’s future2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Reversal indicators forming on ZimVie Inc. stock2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - Newser
ZimVie (ZIMV) Q2 EPS Doubles to $0.26 - AOL.com
What earnings revisions data tells us about ZimVie Inc.July 2025 Rallies & Low Drawdown Investment Strategies - Newser
Key metrics from ZimVie Inc.’s quarterly dataPortfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Combining machine learning predictions for ZimVie Inc.Market Volume Summary & Technical Pattern Alert System - Newser
How to build a custom watchlist for ZimVie Inc.Quarterly Profit Summary & Smart Allocation Stock Reports - Newser
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
Volume Surge May Signal Institutional Interest in ZimVie Inc.2025 Key Lessons & Scalable Portfolio Growth Methods - 선데이타임즈
Can ZimVie Inc. deliver consistent dividendsBreakout to Riches Picks - classian.co.kr
Will ZimVie Inc. see short term momentumHigh Probability Trade Plan with Indicators - Newser
Is ZimVie Inc. stock ready for a breakoutTrend Reversal Watch with Entry Signals - Newser
ZimVie Doubles — And Then Some — On Its Second Takeover Deal - MSN
What analysts say about ZimVie Inc. stockMaximize returns with strategic trading plans - Jammu Links News
Is ZimVie Inc. stock overvalued or undervaluedUnlock expert insights for smarter investing - Jammu Links News
Is ZimVie Inc. a growth stock or a value stockCapitalize on emerging market trends - Jammu Links News
What are ZimVie Inc. company’s key revenue driversInvest smarter with daily stock recommendations - Jammu Links News
What catalysts could drive ZimVie Inc. stock higher in 2025Get timely alerts on top-performing stocks - Jammu Links News
What drives ZimVie Inc. stock priceInvest smarter with comprehensive market analysis - Jammu Links News
What is ZimVie Inc. company’s growth strategyPhenomenal returns - Jammu Links News
When is ZimVie Inc. stock expected to show significant growthFree Trading Strategy Suggestions - Jammu Links News
What are analysts’ price targets for ZimVie Inc. in the next 12 monthsHigh-yield growth strategies - Jammu Links News
How does ZimVie Inc. generate profit in a changing economyMarket Forecast Signals For Fast Growth - Jammu Links News
What is the risk reward ratio of investing in ZimVie Inc. stockMarket Forecast Insights For 2025 - Jammu Links News
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (SAGE) and ZimVie Inc (ZIMV) - The Globe and Mail
Does ZimVie Inc. stock perform well during market downturnsBreakout Stocks Watchlist That Work - jammulinksnews.com
ZimVie Tops Estimates But Preps For ARCHIMED Buyout - Finimize
B.Riley downgrades ZimVie stock rating to Neutral on acquisition news - Investing.com Canada
Real time alert setup for ZimVie Inc. performanceFree Growth Focused Entry Plan Suggestions - Newser
ZimVie Inc. Reports Q2 2025 Results Amid Acquisition - TipRanks
ZimVie earnings beat by $0.03, revenue topped estimates - Investing.com Canada
Zimvie Inc Azioni (ZIMV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zimvie Inc Azioni (ZIMV) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Kidwell Heather | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
8,063 |
0 |
85,880 |
Kanaglekar Indraneel | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
10,966 |
0 |
64,830 |
Jamali Vafa | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
48,379 |
0 |
408,636 |
Heppenstall Richard | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
16,127 |
0 |
130,373 |
Jamali Vafa | See remarks below. |
Apr 01 '25 |
Option Exercise |
0.00 |
21,331 |
0 |
369,590 |
Schneider Sandra | Chief Accounting Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,590 |
0 |
33,252 |
Schneider Sandra | Chief Accounting Officer |
Mar 07 '25 |
Option Exercise |
0.00 |
6,542 |
0 |
31,415 |
Heppenstall Richard | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
6,938 |
0 |
115,936 |
Heppenstall Richard | See remarks below. |
Mar 07 '25 |
Option Exercise |
0.00 |
24,650 |
0 |
115,337 |
Kanaglekar Indraneel | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
4,163 |
0 |
54,878 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):